Clover Health Investments Statistics
Total Valuation
CLOV has a market cap or net worth of $1.83 billion. The enterprise value is $1.64 billion.
Important Dates
The next estimated earnings date is Tuesday, May 6, 2025, after market close.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CLOV has 510.91 million shares outstanding. The number of shares has increased by 1.63% in one year.
| Current Share Class | 418.53M |
| Shares Outstanding | 510.91M |
| Shares Change (YoY) | +1.63% |
| Shares Change (QoQ) | +0.34% |
| Owned by Insiders (%) | 21.13% |
| Owned by Institutions (%) | 18.17% |
| Float | 401.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 41.28 |
| PS Ratio | 1.28 |
| Forward PS | 0.97 |
| PB Ratio | 5.30 |
| P/TBV Ratio | 5.42 |
| P/FCF Ratio | 55.10 |
| P/OCF Ratio | 52.64 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 49.25 |
Financial Position
The company has a current ratio of 1.61
| Current Ratio | 1.61 |
| Quick Ratio | 1.47 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -14.75% and return on invested capital (ROIC) is -9.15%.
| Return on Equity (ROE) | -14.75% |
| Return on Assets (ROA) | -4.99% |
| Return on Invested Capital (ROIC) | -9.15% |
| Return on Capital Employed (ROCE) | -12.51% |
| Revenue Per Employee | $2.40M |
| Profits Per Employee | -$75,454 |
| Employee Count | 570 |
| Asset Turnover | 2.38 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +352.71% in the last 52 weeks. The beta is 2.01, so CLOV's price volatility has been higher than the market average.
| Beta (5Y) | 2.01 |
| 52-Week Price Change | +352.71% |
| 50-Day Moving Average | 4.11 |
| 200-Day Moving Average | 3.14 |
| Relative Strength Index (RSI) | 42.02 |
| Average Volume (20 Days) | 5,955,548 |
Short Selling Information
The latest short interest is 13.14 million, so 2.57% of the outstanding shares have been sold short.
| Short Interest | 13.14M |
| Short Previous Month | 11.90M |
| Short % of Shares Out | 2.57% |
| Short % of Float | 3.28% |
| Short Ratio (days to cover) | 1.99 |
Income Statement
In the last 12 months, CLOV had revenue of $1.37 billion and -$43.01 million in losses. Loss per share was -$0.09.
| Revenue | 1.37B |
| Gross Profit | 364.34M |
| Operating Income | -45.93M |
| Pretax Income | -123.70M |
| Net Income | -43.01M |
| EBITDA | -44.60M |
| EBIT | -45.93M |
| Loss Per Share | -$0.09 |
Full Income StatementBalance Sheet
The company has $221.56 million in cash and n/a in debt, giving a net cash position of $194.54 million or $0.38 per share.
| Cash & Cash Equivalents | 221.56M |
| Total Debt | n/a |
| Net Cash | 194.54M |
| Net Cash Per Share | $0.38 |
| Equity (Book Value) | 341.14M |
| Book Value Per Share | 0.68 |
| Working Capital | 129.61M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $34.85 million and capital expenditures -$1.56 million, giving a free cash flow of $33.29 million.
| Operating Cash Flow | 34.85M |
| Capital Expenditures | -1.56M |
| Free Cash Flow | 33.29M |
| FCF Per Share | $0.07 |
Full Cash Flow StatementMargins
Gross margin is 26.58%, with operating and profit margins of -3.35% and -3.14%.
| Gross Margin | 26.58% |
| Operating Margin | -3.35% |
| Pretax Margin | -3.38% |
| Profit Margin | -3.14% |
| EBITDA Margin | -3.25% |
| EBIT Margin | -3.35% |
| FCF Margin | 2.43% |